Crossmark

Should All Patients with Resistant Hypertension Receive Spironolactone?

Crossref DOI link: https://doi.org/10.1007/s11906-016-0690-1

Published Online: 2016-10-27

Published Print: 2016-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rosa, Ján

Zelinka, Tomáš

Petrák, Ondřej

Štrauch, Branislav

Holaj, Robert

Widimský, Jiří Jr
Funding

Funding for this research was provided by:

Charles University Research Projects (UNCE 204010 and PRVOUK P35)

Ministry of Health of the Czech Republic (16-30345A)
License Information

Text and Data Mining valid from 2016-10-27
More Information

Article History

First Online: 27 October 2016

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.

: This article does not contain any studies with human or animal subjects performed by any of the authors.